• Print This Page
  •  
  • Email This Page
  •  
  • RSS

Practices

Education

Bar Admissions

Court Admissions

Memberships

Other Distinctions

Expand All >>
Biography Press Room

Alicia Batts is a Partner in the Litigation Department, resident in the Washington, D.C. office. An antitrust litigator who represents clients in the federal courts and before federal and state agencies, and provides counsel on related matters to companies in a range of industries, she also brings valuable experience from her past work as an antitrust advisor at the Federal Trade Commission.

Alicia's practice concentrates on all issues relating to unfair trade practices, and she regularly represents clients before antitrust enforcement agencies and in federal antitrust cases. She also has extensive experience representing and providing antitrust counseling for companies in a range of industries, including automotive, aeronautics, pharmaceutical, financial and energy.

Alicia previously worked at Dickstein Shapiro LLP, where she was a partner. She also has worked as an antitrust advisor to Federal Trade Commissioner Mozelle Thompson, for whom she reviewed antitrust actions before the FTC and made recommendations on enforcement and policy matters before the Federal Antitrust Agency.

Earlier this year, Alicia represented Grifols, S.A., a global health care company and leading producer of plasma protein therapies, in reaching an agreement to acquire its rival, Talecris Biotherapeutics Holdings Corp., creating the world's third-largest plasma-products manufacturer and allowing Grifols to double its plasma collection and fractionation capacity. The deal included a $375 million break-up fee payable to Talecris if the deal did not close as a result of a failure to obtain antitrust clearance (or financing). This brought to an end a year of intense scrutiny of the deal by the FTC, including the risk of antitrust litigation to prevent the deal from closing, similar to FTC litigation brought against a previous unsuccessful bidder for Talecris.

She also recently represented a company that collects and provides pricing data to participants in the derivatives industry providing antitrust advice on transactions and counseling advice as well as defending the company in DOJ investigations.

In the past, Alicia has represented a distributor of dental and animal health care products providing counseling, strategic and litigation advice; a private equity firm, providing distribution advice and antitrust advice on transactions; a worldwide credit and charge card network in defense of allegations that exclusivity agreements with issuers violated antitrust laws; a hospital association in a class action filed against a teaching hospital and medical associations and programs; and a large distributor purchasing a competitor in a highly concentrated market.

A regular panelist at antitrust conferences, she also is a former member of the board of directors of the Appleseed Foundation.

© 2012 Proskauer Rose LLP. All Rights Reserved.